American Capital Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.1K Buy
48
+9
+23% +$4.32K 0.01% 288
2026
Q1
$19.2K Buy
39
+4
+11% +$2.17K 0.01% 293
2025
Q4
$20.3K Buy
35
+2
+6% +$1.13K 0.01% 280
2025
Q3
$16K Hold
33
0.01% 281
2025
Q2
$13.4K Buy
33
+8
+32% +$3.35K 0.01% 282
2025
Q1
$12.4K Hold
25
0.01% 286
2024
Q4
$13K Hold
25
0.01% 279
2024
Q3
$15.5K Hold
25
0.01% 265
2024
Q2
$13.3K Hold
25
0.01% 240
2024
Q1
$14.4K Hold
25
0.01% 227
2023
Q4
$13.3K Buy
+25
New +$12.1K 0.01% 240

Other funds holding TMO

American Capital Advisory's TMO Position: Q2 2026 in Review

American Capital Advisory increased its Thermo Fisher Scientific (TMO) stake by 23% in Q2 2026, buying an estimated $4.32K and bringing the position to 48 shares worth $24.1K. The position accounts for 0.01% of the portfolio, ranked #288.

American Capital Advisory first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • American Capital Advisory held 48 shares of Thermo Fisher Scientific worth $24.1K as of Q2 2026.
  • American Capital Advisory bought 9 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.32K.
  • Thermo Fisher Scientific made up 0.01% of American Capital Advisory's portfolio in Q2 2026, its #288 holding.
  • American Capital Advisory first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.